Loading...
HSChapter 30
U.S. exports of mixed immunological products, not in measured doses (not for retail sale) (HS 300214) totaled $868.8M in July 2026.
Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale) imports of $689.3M in July 2026 ran 22% above the year-to-date monthly average of $566.4M.
Last updated: July 2026 dataBulk mixed immunological preparations — including those based on monoclonal antibodies — that have not yet been packaged into measured doses fall here, distinguishing them from retail-ready formulations. FDA's Center for Biologics Evaluation and Research (CBER) governs admissibility, and importers must ensure the foreign establishment holds the appropriate biologics license or operates under an FDA import authorization. Ireland and South Korea are the leading US suppliers under this heading, reflecting the concentration of large-scale biologics contract manufacturing in those markets. The US schedule separates monoclonal-antibody-containing products (3002140010) from other mixed immunological preparations (3002140090), a distinction that can affect both classification and FDA review pathways.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
646 shipments/mo
The key split is whether the mixed immunological product contains monoclonal antibodies (3002140010) versus other immunological mixtures (3002140090). Both require FDA CBER oversight, but monoclonal-antibody products may trigger additional biologics license application (BLA) review and distinct labeling requirements. Importers should confirm classification with a licensed customs broker before entry.
Importers generally need an FDA establishment registration for the foreign manufacturer, a valid biologics license or import authorization, a commercial invoice specifying the product's composition and intended use, and compliance with FDA's prior notice and entry filing requirements. Because admissibility rules are complex, consulting a licensed customs broker and regulatory counsel is strongly advised.
Supplier Network
Get discovered by U.S. importers searching for HS 300214 — Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale). Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3002140010 | Immun Prod W Monoclonal Antibodies, Not for Retail | $651.4M | 0.0010% | 0.0041% | $6K |
| 3002140090 | Immunological Products, Mixed, Not for Retail Sale | $37.9M | 0.00% | 0.00% | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3002140000 | Immunological Products,Mixed, N for Retail Sale | $868.8M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$689.3MYoY · Pro
Exports
$868.8MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Exports · July 2026
destination
customs district
origin
entry
rate provision · imports
100.0% enters free of duty; the effective duty rate is 0.00%.